VEON’s Kyivstar Gains Regulatory Approval for Starlink Direct-to-Cell Testing in Ukraine

VEON
September 19, 2025
VEON Ltd. announced on June 27, 2025, that its Ukrainian subsidiary, Kyivstar, has received regulatory approval to begin testing Starlink Direct-to-Cell (D2C) services. The approval was granted by the Ukrainian National Commission for the State Regulation of Electronic Communications. This regulatory milestone is a crucial step in operationalizing the groundbreaking agreement signed in December 2024 between Kyivstar and Starlink. The D2C service is expected to enhance the resilience of Ukraine’s connectivity landscape, providing satellite-powered connectivity even when terrestrial networks are unavailable. The ability to test these advanced services is vital for ensuring robust communication infrastructure in Ukraine, particularly given the ongoing challenges. This development reinforces VEON's commitment to investing in Ukraine's digital future and leveraging cutting-edge technology for its customers. The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.